Form 4: AngioDynamics Director Wesley Johnson Acquires Shares as Part of Compensation Package

Director Wesley Johnson acquired 20,541 shares of AngioDynamics common stock as part of his annual compensation for serving as a director.

Summary

• On July 17, 2024, Wesley Johnson, a director of AngioDynamics Inc., acquired 20,541 shares of common stock.
• The acquisition was in the form of restricted stock units granted as annual compensation for his service as a director.
• The restricted stock units vested immediately upon grant.
• Following the transaction, Johnson beneficially owns 125,863 shares of AngioDynamics stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a routine transaction related to director compensation. It doesn't indicate any significant positive or negative developments for the company.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Industry Context

Director compensation in the form of stock grants is a common practice in publicly traded companies to align the interests of directors with those of shareholders.

Comparison to Industry Standards

• Stock grants to directors are a typical component of compensation packages in publicly traded companies like AngioDynamics.
• Companies such as Medtronic, Boston Scientific, and Abbott also utilize stock grants as part of their director compensation plans.
• The size of the grant is generally determined by the company's compensation committee and is benchmarked against peer companies in the medical device industry.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with those of the shareholders.

Key Dates